Literature DB >> 9199435

Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis.

R Bhushan1, C Kirkham, S Sethi, T F Murphy.   

Abstract

Outer membrane protein E (OMP E) is a 50-kDa major OMP of Branhamella catarrhalis. Polyclonal antisera and four monoclonal antibodies (MAbs) to OMP E were generated to study its antigenic structure. All antibodies recognized epitopes in all 19 B. catarrhalis strains tested by immunoblot assays. By flow cytometry, it was determined that MAbs 1B3 and 9G10d recognized epitopes which are expressed on the surface of the intact bacterium, while MAbs IC11 and 7C10 recognized epitopes which were buried within the outer membrane. A competitive enzyme-linked immunosorbent assay showed that MAbs 1B3 and 9G10d recognize the same or closely related epitopes. Proteinase K treatment of whole bacterial cells revealed that MAbs 1B3 and 9G10d recognize a surface-exposed epitope located in the 17-kDa region towards the amino terminus of OMP E. The human serum and mucosal antibody responses to OMP E in adults with chronic bronchitis were studied. A majority of these patients had immunoglobulin A to OMP E in sputum supernatants. None of ten adults who experienced lower respiratory tract infections due to B. catarrhalis demonstrated a clear-cut rise in antibody titer to OMP E in serum or sputum supernatant. This study has demonstrated that OMP E has at least one surface-exposed epitope which is highly conserved among strains of B. catarrhalis and which is located in the amino-terminal 184 amino acids of the molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199435      PMCID: PMC175377          DOI: 10.1128/iai.65.7.2668-2675.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  New concepts in otitis media: results of investigations of the Greater Boston Otitis Media Study Group.

Authors:  J O Klein; D W Teele; S I Pelton
Journal:  Adv Pediatr       Date:  1992

Review 2.  Bacterial infection in chronic obstructive pulmonary disease.

Authors:  T F Murphy; S Sethi
Journal:  Am Rev Respir Dis       Date:  1992-10

3.  From Micrococcus to Moraxella. The reemergence of Branhamella catarrhalis.

Authors:  S L Berk
Journal:  Arch Intern Med       Date:  1990-11

4.  A recombinant non-fatty acylated form of the Hi-PAL (P6) protein of Haemophilus influenzae elicits biologically active antibody against both nontypeable and type b H. influenzae.

Authors:  B A Green; B J Metcalf; T Quinn-Dey; D H Kirkley; S A Quataert; R A Deich
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy; L C Bartos
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

Review 6.  Studies of the outer membrane proteins of Branhamella catarrhalis.

Authors:  T F Murphy
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

7.  The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene.

Authors:  B A Green; J E Farley; T Quinn-Dey; R A Deich; G W Zlotnick
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 8.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

9.  Importance of an immunodominant surface-exposed loop on outer membrane protein P2 of nontypeable Haemophilus influenzae.

Authors:  K Yi; T F Murphy
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

10.  Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

Authors:  J Sarwar; A A Campagnari; C Kirkham; T F Murphy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more
  16 in total

1.  Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.

Authors:  T F Murphy; C Kirkham; E DeNardin; S Sethi
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 4.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 5.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities.

Authors:  Melanie M Pearson; Eric R Lafontaine; Nikki J Wagner; Joseph W St Geme; Eric J Hansen
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.

Authors:  Elizabeth A Ruckdeschel; Charmaine Kirkham; Alan J Lesse; Zihua Hu; Timothy F Murphy
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

Review 8.  Vaccine targets against Moraxella catarrhalis.

Authors:  Dabin Ren; Michael E Pichichero
Journal:  Expert Opin Ther Targets       Date:  2015-08-26       Impact factor: 6.902

9.  Metabolic analysis of Moraxella catarrhalis and the effect of selected in vitro growth conditions on global gene expression.

Authors:  Wei Wang; Larry Reitzer; David A Rasko; Melanie M Pearson; Robert J Blick; Cassie Laurence; Eric J Hansen
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

Review 10.  Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.

Authors:  Timothy F Murphy; Sanjay Sethi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.